Contraception in diabetic women.

Area of Science:

• Reproductive Endocrinology
• Metabolic Disorders
• Contraception

Background:

• Diabetic women face unique considerations regarding contraceptive choices.
• Previous research has not fully elucidated the safety of intrauterine devices (IUDs) and oral contraceptives (OCs) in this population.

Purpose of the Study:

• To investigate the clinical outcomes of intrauterine contraception in diabetic women.
• To assess the influence of oral contraceptives on glucose and lipid metabolism in women with diabetes.

Main Methods:

• Studied copper-T IUD insertion in insulin-dependent diabetic women.
• Analyzed accidental pregnancy and continuation rates at 12 months.
• Evaluated glucose tolerance and serum lipoprotein levels in women with previous gestational diabetes using low-dose hormonal contraceptives.
• Assessed oral contraceptive use (natural estrogen) in insulin-dependent diabetic women.

Main Results:

• Copper-T IUDs showed comparable pregnancy and continuation rates in diabetic versus non-diabetic women.
• No significant differences in IUD corrosion were observed.
• Low-dose hormonal contraceptives did not alter glucose tolerance or lipoprotein levels in women with prior gestational diabetes.
• Oral contraceptives with natural estrogen did not impede diabetes control or lipid metabolism in insulin-dependent diabetic women.

Conclusions:

• Intrauterine contraception, including copper-T IUDs, is a safe and effective option for diabetic women.
• Low-dose oral contraceptives and those containing natural estrogen are suitable for diabetic women, without adverse effects on metabolic control or lipid profiles.